nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—peripheral nervous system neoplasm—skin cancer	0.815	1	CtDrD
Isotretinoin—RXRG—neck—skin cancer	0.00165	0.119	CbGeAlD
Isotretinoin—RARG—nipple—skin cancer	0.00139	0.1	CbGeAlD
Isotretinoin—RXRA—female reproductive system—skin cancer	0.000947	0.0686	CbGeAlD
Isotretinoin—RARG—skin of body—skin cancer	0.000889	0.0643	CbGeAlD
Isotretinoin—RARB—female reproductive system—skin cancer	0.000851	0.0616	CbGeAlD
Isotretinoin—RARG—mammalian vulva—skin cancer	0.00081	0.0587	CbGeAlD
Isotretinoin—RXRA—head—skin cancer	0.000791	0.0573	CbGeAlD
Isotretinoin—RARB—head—skin cancer	0.000711	0.0515	CbGeAlD
Isotretinoin—RXRG—head—skin cancer	0.000695	0.0503	CbGeAlD
Isotretinoin—RARG—female reproductive system—skin cancer	0.000694	0.0502	CbGeAlD
Isotretinoin—RARA—lymphoid tissue—skin cancer	0.000677	0.049	CbGeAlD
Isotretinoin—RXRB—head—skin cancer	0.000653	0.0473	CbGeAlD
Isotretinoin—RARA—female reproductive system—skin cancer	0.000653	0.0472	CbGeAlD
Isotretinoin—RARG—head—skin cancer	0.00058	0.042	CbGeAlD
Isotretinoin—RARA—head—skin cancer	0.000545	0.0395	CbGeAlD
Isotretinoin—RARB—lymph node—skin cancer	0.000498	0.036	CbGeAlD
Isotretinoin—RARG—lymph node—skin cancer	0.000406	0.0294	CbGeAlD
Isotretinoin—RARA—lymph node—skin cancer	0.000382	0.0276	CbGeAlD
Isotretinoin—Angiopathy—Temozolomide—skin cancer	0.000104	0.000607	CcSEcCtD
Isotretinoin—Cough—Bleomycin—skin cancer	0.000103	0.000602	CcSEcCtD
Isotretinoin—Chills—Temozolomide—skin cancer	0.000103	0.0006	CcSEcCtD
Isotretinoin—Dehydration—Docetaxel—skin cancer	0.000102	0.000598	CcSEcCtD
Isotretinoin—Ill-defined disorder—Dactinomycin—skin cancer	0.000102	0.000597	CcSEcCtD
Isotretinoin—Anaemia—Dactinomycin—skin cancer	0.000102	0.000595	CcSEcCtD
Isotretinoin—Vomiting—Vemurafenib—skin cancer	0.000101	0.000591	CcSEcCtD
Isotretinoin—Alopecia—Temozolomide—skin cancer	0.000101	0.000591	CcSEcCtD
Isotretinoin—Dry skin—Docetaxel—skin cancer	0.000101	0.00059	CcSEcCtD
Isotretinoin—Chest pain—Bleomycin—skin cancer	0.000101	0.000588	CcSEcCtD
Isotretinoin—Myalgia—Bleomycin—skin cancer	0.000101	0.000588	CcSEcCtD
Isotretinoin—Rash—Vemurafenib—skin cancer	0.0001	0.000586	CcSEcCtD
Isotretinoin—Mental disorder—Temozolomide—skin cancer	0.0001	0.000586	CcSEcCtD
Isotretinoin—Dermatitis—Vemurafenib—skin cancer	0.0001	0.000586	CcSEcCtD
Isotretinoin—Hypersensitivity—Imiquimod—skin cancer	0.0001	0.000584	CcSEcCtD
Isotretinoin—Headache—Vemurafenib—skin cancer	9.98e-05	0.000583	CcSEcCtD
Isotretinoin—Malnutrition—Temozolomide—skin cancer	9.98e-05	0.000582	CcSEcCtD
Isotretinoin—Erythema—Temozolomide—skin cancer	9.98e-05	0.000582	CcSEcCtD
Isotretinoin—Discomfort—Bleomycin—skin cancer	9.95e-05	0.000581	CcSEcCtD
Isotretinoin—Malaise—Dactinomycin—skin cancer	9.95e-05	0.000581	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Docetaxel—skin cancer	9.92e-05	0.000579	CcSEcCtD
Isotretinoin—Nasopharyngitis—Docetaxel—skin cancer	9.86e-05	0.000575	CcSEcCtD
Isotretinoin—Asthenia—Imiquimod—skin cancer	9.75e-05	0.000569	CcSEcCtD
Isotretinoin—Confusional state—Bleomycin—skin cancer	9.74e-05	0.000568	CcSEcCtD
Isotretinoin—Anaphylactic shock—Bleomycin—skin cancer	9.66e-05	0.000563	CcSEcCtD
Isotretinoin—Oedema—Bleomycin—skin cancer	9.66e-05	0.000563	CcSEcCtD
Isotretinoin—Back pain—Temozolomide—skin cancer	9.65e-05	0.000563	CcSEcCtD
Isotretinoin—Pruritus—Imiquimod—skin cancer	9.62e-05	0.000561	CcSEcCtD
Isotretinoin—Infection—Bleomycin—skin cancer	9.59e-05	0.00056	CcSEcCtD
Isotretinoin—Dysphagia—Docetaxel—skin cancer	9.53e-05	0.000556	CcSEcCtD
Isotretinoin—Nausea—Vemurafenib—skin cancer	9.47e-05	0.000552	CcSEcCtD
Isotretinoin—Thrombocytopenia—Bleomycin—skin cancer	9.45e-05	0.000552	CcSEcCtD
Isotretinoin—Arrhythmia—Fluorouracil—skin cancer	9.44e-05	0.000551	CcSEcCtD
Isotretinoin—Vision blurred—Temozolomide—skin cancer	9.41e-05	0.000549	CcSEcCtD
Isotretinoin—Myalgia—Dactinomycin—skin cancer	9.39e-05	0.000548	CcSEcCtD
Isotretinoin—Bronchospasm—Docetaxel—skin cancer	9.37e-05	0.000547	CcSEcCtD
Isotretinoin—Tremor—Temozolomide—skin cancer	9.35e-05	0.000546	CcSEcCtD
Isotretinoin—Alopecia—Fluorouracil—skin cancer	9.33e-05	0.000545	CcSEcCtD
Isotretinoin—Diarrhoea—Imiquimod—skin cancer	9.3e-05	0.000543	CcSEcCtD
Isotretinoin—Discomfort—Dactinomycin—skin cancer	9.28e-05	0.000542	CcSEcCtD
Isotretinoin—Ill-defined disorder—Temozolomide—skin cancer	9.26e-05	0.00054	CcSEcCtD
Isotretinoin—Anaemia—Temozolomide—skin cancer	9.22e-05	0.000538	CcSEcCtD
Isotretinoin—Anorexia—Bleomycin—skin cancer	9.2e-05	0.000537	CcSEcCtD
Isotretinoin—Erythema—Fluorouracil—skin cancer	9.2e-05	0.000537	CcSEcCtD
Isotretinoin—Agitation—Temozolomide—skin cancer	9.17e-05	0.000535	CcSEcCtD
Isotretinoin—Hypotension—Bleomycin—skin cancer	9.02e-05	0.000527	CcSEcCtD
Isotretinoin—Oedema—Dactinomycin—skin cancer	9.01e-05	0.000526	CcSEcCtD
Isotretinoin—Malaise—Temozolomide—skin cancer	9e-05	0.000525	CcSEcCtD
Isotretinoin—Dizziness—Imiquimod—skin cancer	8.99e-05	0.000525	CcSEcCtD
Isotretinoin—Infection—Dactinomycin—skin cancer	8.95e-05	0.000522	CcSEcCtD
Isotretinoin—Neutropenia—Docetaxel—skin cancer	8.91e-05	0.00052	CcSEcCtD
Isotretinoin—Palpitations—Temozolomide—skin cancer	8.82e-05	0.000515	CcSEcCtD
Isotretinoin—Thrombocytopenia—Dactinomycin—skin cancer	8.82e-05	0.000515	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Bleomycin—skin cancer	8.8e-05	0.000513	CcSEcCtD
Isotretinoin—Cough—Temozolomide—skin cancer	8.71e-05	0.000508	CcSEcCtD
Isotretinoin—Paraesthesia—Bleomycin—skin cancer	8.67e-05	0.000506	CcSEcCtD
Isotretinoin—Weight increased—Docetaxel—skin cancer	8.67e-05	0.000506	CcSEcCtD
Isotretinoin—Vision blurred—Fluorouracil—skin cancer	8.67e-05	0.000506	CcSEcCtD
Isotretinoin—Convulsion—Temozolomide—skin cancer	8.65e-05	0.000505	CcSEcCtD
Isotretinoin—Vomiting—Imiquimod—skin cancer	8.64e-05	0.000504	CcSEcCtD
Isotretinoin—Weight decreased—Docetaxel—skin cancer	8.62e-05	0.000503	CcSEcCtD
Isotretinoin—Hypertension—Temozolomide—skin cancer	8.62e-05	0.000503	CcSEcCtD
Isotretinoin—Dyspnoea—Bleomycin—skin cancer	8.61e-05	0.000502	CcSEcCtD
Isotretinoin—Anorexia—Dactinomycin—skin cancer	8.58e-05	0.000501	CcSEcCtD
Isotretinoin—Rash—Imiquimod—skin cancer	8.57e-05	0.0005	CcSEcCtD
Isotretinoin—Dermatitis—Imiquimod—skin cancer	8.56e-05	0.0005	CcSEcCtD
Isotretinoin—Pneumonia—Docetaxel—skin cancer	8.54e-05	0.000499	CcSEcCtD
Isotretinoin—Headache—Imiquimod—skin cancer	8.52e-05	0.000497	CcSEcCtD
Isotretinoin—Anaemia—Fluorouracil—skin cancer	8.5e-05	0.000496	CcSEcCtD
Isotretinoin—Arthralgia—Temozolomide—skin cancer	8.5e-05	0.000496	CcSEcCtD
Isotretinoin—Myalgia—Temozolomide—skin cancer	8.5e-05	0.000496	CcSEcCtD
Isotretinoin—Infestation NOS—Docetaxel—skin cancer	8.49e-05	0.000496	CcSEcCtD
Isotretinoin—Infestation—Docetaxel—skin cancer	8.49e-05	0.000496	CcSEcCtD
Isotretinoin—Anxiety—Temozolomide—skin cancer	8.47e-05	0.000494	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	8.44e-05	0.000492	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	8.42e-05	0.000491	CcSEcCtD
Isotretinoin—Discomfort—Temozolomide—skin cancer	8.4e-05	0.00049	CcSEcCtD
Isotretinoin—Decreased appetite—Bleomycin—skin cancer	8.39e-05	0.00049	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Docetaxel—skin cancer	8.37e-05	0.000489	CcSEcCtD
Isotretinoin—Renal failure—Docetaxel—skin cancer	8.35e-05	0.000487	CcSEcCtD
Isotretinoin—Myocardial infarction—Docetaxel—skin cancer	8.33e-05	0.000486	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Docetaxel—skin cancer	8.33e-05	0.000486	CcSEcCtD
Isotretinoin—Dry mouth—Temozolomide—skin cancer	8.31e-05	0.000485	CcSEcCtD
Isotretinoin—Stomatitis—Docetaxel—skin cancer	8.28e-05	0.000483	CcSEcCtD
Isotretinoin—Pain—Bleomycin—skin cancer	8.26e-05	0.000482	CcSEcCtD
Isotretinoin—Conjunctivitis—Docetaxel—skin cancer	8.26e-05	0.000482	CcSEcCtD
Isotretinoin—Confusional state—Temozolomide—skin cancer	8.21e-05	0.000479	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	8.21e-05	0.000479	CcSEcCtD
Isotretinoin—Oedema—Temozolomide—skin cancer	8.15e-05	0.000475	CcSEcCtD
Isotretinoin—Anaphylactic shock—Temozolomide—skin cancer	8.15e-05	0.000475	CcSEcCtD
Isotretinoin—Infection—Temozolomide—skin cancer	8.09e-05	0.000472	CcSEcCtD
Isotretinoin—Nausea—Imiquimod—skin cancer	8.07e-05	0.000471	CcSEcCtD
Isotretinoin—Epistaxis—Docetaxel—skin cancer	8.01e-05	0.000467	CcSEcCtD
Isotretinoin—Nervous system disorder—Temozolomide—skin cancer	7.99e-05	0.000466	CcSEcCtD
Isotretinoin—Thrombocytopenia—Temozolomide—skin cancer	7.98e-05	0.000465	CcSEcCtD
Isotretinoin—Convulsion—Fluorouracil—skin cancer	7.97e-05	0.000465	CcSEcCtD
Isotretinoin—Feeling abnormal—Bleomycin—skin cancer	7.96e-05	0.000464	CcSEcCtD
Isotretinoin—Agranulocytosis—Docetaxel—skin cancer	7.93e-05	0.000463	CcSEcCtD
Isotretinoin—Skin disorder—Temozolomide—skin cancer	7.91e-05	0.000462	CcSEcCtD
Isotretinoin—Hyperhidrosis—Temozolomide—skin cancer	7.87e-05	0.00046	CcSEcCtD
Isotretinoin—Chest pain—Fluorouracil—skin cancer	7.83e-05	0.000457	CcSEcCtD
Isotretinoin—Myalgia—Fluorouracil—skin cancer	7.83e-05	0.000457	CcSEcCtD
Isotretinoin—Decreased appetite—Dactinomycin—skin cancer	7.83e-05	0.000457	CcSEcCtD
Isotretinoin—Fatigue—Dactinomycin—skin cancer	7.76e-05	0.000453	CcSEcCtD
Isotretinoin—Anorexia—Temozolomide—skin cancer	7.76e-05	0.000453	CcSEcCtD
Isotretinoin—Discomfort—Fluorouracil—skin cancer	7.74e-05	0.000451	CcSEcCtD
Isotretinoin—Pain—Dactinomycin—skin cancer	7.7e-05	0.000449	CcSEcCtD
Isotretinoin—Urticaria—Bleomycin—skin cancer	7.67e-05	0.000448	CcSEcCtD
Isotretinoin—Haemoglobin—Docetaxel—skin cancer	7.66e-05	0.000447	CcSEcCtD
Isotretinoin—Body temperature increased—Bleomycin—skin cancer	7.63e-05	0.000445	CcSEcCtD
Isotretinoin—Haemorrhage—Docetaxel—skin cancer	7.62e-05	0.000445	CcSEcCtD
Isotretinoin—Hepatitis—Docetaxel—skin cancer	7.62e-05	0.000445	CcSEcCtD
Isotretinoin—Hypoaesthesia—Docetaxel—skin cancer	7.59e-05	0.000443	CcSEcCtD
Isotretinoin—Confusional state—Fluorouracil—skin cancer	7.57e-05	0.000442	CcSEcCtD
Isotretinoin—Pharyngitis—Docetaxel—skin cancer	7.57e-05	0.000442	CcSEcCtD
Isotretinoin—Urinary tract disorder—Docetaxel—skin cancer	7.53e-05	0.000439	CcSEcCtD
Isotretinoin—Oedema peripheral—Docetaxel—skin cancer	7.51e-05	0.000438	CcSEcCtD
Isotretinoin—Oedema—Fluorouracil—skin cancer	7.51e-05	0.000438	CcSEcCtD
Isotretinoin—Anaphylactic shock—Fluorouracil—skin cancer	7.51e-05	0.000438	CcSEcCtD
Isotretinoin—Urethral disorder—Docetaxel—skin cancer	7.47e-05	0.000436	CcSEcCtD
Isotretinoin—Infection—Fluorouracil—skin cancer	7.46e-05	0.000435	CcSEcCtD
Isotretinoin—Feeling abnormal—Dactinomycin—skin cancer	7.42e-05	0.000433	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Temozolomide—skin cancer	7.42e-05	0.000433	CcSEcCtD
Isotretinoin—Insomnia—Temozolomide—skin cancer	7.37e-05	0.00043	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Dactinomycin—skin cancer	7.36e-05	0.00043	CcSEcCtD
Isotretinoin—Nervous system disorder—Fluorouracil—skin cancer	7.36e-05	0.000429	CcSEcCtD
Isotretinoin—Thrombocytopenia—Fluorouracil—skin cancer	7.35e-05	0.000429	CcSEcCtD
Isotretinoin—Visual impairment—Docetaxel—skin cancer	7.35e-05	0.000429	CcSEcCtD
Isotretinoin—Tachycardia—Fluorouracil—skin cancer	7.32e-05	0.000427	CcSEcCtD
Isotretinoin—Paraesthesia—Temozolomide—skin cancer	7.31e-05	0.000427	CcSEcCtD
Isotretinoin—Dyspnoea—Temozolomide—skin cancer	7.26e-05	0.000424	CcSEcCtD
Isotretinoin—Somnolence—Temozolomide—skin cancer	7.24e-05	0.000423	CcSEcCtD
Isotretinoin—Erythema multiforme—Docetaxel—skin cancer	7.21e-05	0.000421	CcSEcCtD
Isotretinoin—Dyspepsia—Temozolomide—skin cancer	7.17e-05	0.000418	CcSEcCtD
Isotretinoin—Anorexia—Fluorouracil—skin cancer	7.15e-05	0.000417	CcSEcCtD
Isotretinoin—Eye disorder—Docetaxel—skin cancer	7.13e-05	0.000416	CcSEcCtD
Isotretinoin—Abdominal pain—Dactinomycin—skin cancer	7.12e-05	0.000415	CcSEcCtD
Isotretinoin—Body temperature increased—Dactinomycin—skin cancer	7.12e-05	0.000415	CcSEcCtD
Isotretinoin—Hypersensitivity—Bleomycin—skin cancer	7.11e-05	0.000415	CcSEcCtD
Isotretinoin—Decreased appetite—Temozolomide—skin cancer	7.08e-05	0.000413	CcSEcCtD
Isotretinoin—Flushing—Docetaxel—skin cancer	7.08e-05	0.000413	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Temozolomide—skin cancer	7.03e-05	0.00041	CcSEcCtD
Isotretinoin—Fatigue—Temozolomide—skin cancer	7.02e-05	0.00041	CcSEcCtD
Isotretinoin—Hypotension—Fluorouracil—skin cancer	7.01e-05	0.000409	CcSEcCtD
Isotretinoin—Constipation—Temozolomide—skin cancer	6.97e-05	0.000406	CcSEcCtD
Isotretinoin—Pain—Temozolomide—skin cancer	6.97e-05	0.000406	CcSEcCtD
Isotretinoin—Asthenia—Bleomycin—skin cancer	6.93e-05	0.000404	CcSEcCtD
Isotretinoin—Angiopathy—Docetaxel—skin cancer	6.92e-05	0.000404	CcSEcCtD
Isotretinoin—Chills—Docetaxel—skin cancer	6.84e-05	0.000399	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	6.84e-05	0.000399	CcSEcCtD
Isotretinoin—Pruritus—Bleomycin—skin cancer	6.83e-05	0.000399	CcSEcCtD
Isotretinoin—Arrhythmia—Docetaxel—skin cancer	6.81e-05	0.000397	CcSEcCtD
Isotretinoin—Insomnia—Fluorouracil—skin cancer	6.79e-05	0.000396	CcSEcCtD
Isotretinoin—Paraesthesia—Fluorouracil—skin cancer	6.74e-05	0.000393	CcSEcCtD
Isotretinoin—Alopecia—Docetaxel—skin cancer	6.74e-05	0.000393	CcSEcCtD
Isotretinoin—Feeling abnormal—Temozolomide—skin cancer	6.71e-05	0.000392	CcSEcCtD
Isotretinoin—Dyspnoea—Fluorouracil—skin cancer	6.69e-05	0.00039	CcSEcCtD
Isotretinoin—Mental disorder—Docetaxel—skin cancer	6.68e-05	0.00039	CcSEcCtD
Isotretinoin—Somnolence—Fluorouracil—skin cancer	6.67e-05	0.000389	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Temozolomide—skin cancer	6.66e-05	0.000389	CcSEcCtD
Isotretinoin—Malnutrition—Docetaxel—skin cancer	6.64e-05	0.000387	CcSEcCtD
Isotretinoin—Erythema—Docetaxel—skin cancer	6.64e-05	0.000387	CcSEcCtD
Isotretinoin—Hypersensitivity—Dactinomycin—skin cancer	6.64e-05	0.000387	CcSEcCtD
Isotretinoin—Dyspepsia—Fluorouracil—skin cancer	6.61e-05	0.000386	CcSEcCtD
Isotretinoin—Decreased appetite—Fluorouracil—skin cancer	6.52e-05	0.000381	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Fluorouracil—skin cancer	6.48e-05	0.000378	CcSEcCtD
Isotretinoin—Urticaria—Temozolomide—skin cancer	6.47e-05	0.000378	CcSEcCtD
Isotretinoin—Asthenia—Dactinomycin—skin cancer	6.46e-05	0.000377	CcSEcCtD
Isotretinoin—Abdominal pain—Temozolomide—skin cancer	6.44e-05	0.000376	CcSEcCtD
Isotretinoin—Body temperature increased—Temozolomide—skin cancer	6.44e-05	0.000376	CcSEcCtD
Isotretinoin—Back pain—Docetaxel—skin cancer	6.42e-05	0.000375	CcSEcCtD
Isotretinoin—Pain—Fluorouracil—skin cancer	6.42e-05	0.000375	CcSEcCtD
Isotretinoin—Feeling abnormal—Fluorouracil—skin cancer	6.18e-05	0.000361	CcSEcCtD
Isotretinoin—Diarrhoea—Dactinomycin—skin cancer	6.16e-05	0.00036	CcSEcCtD
Isotretinoin—Vomiting—Bleomycin—skin cancer	6.14e-05	0.000358	CcSEcCtD
Isotretinoin—Anaemia—Docetaxel—skin cancer	6.13e-05	0.000358	CcSEcCtD
Isotretinoin—Rash—Bleomycin—skin cancer	6.09e-05	0.000355	CcSEcCtD
Isotretinoin—Dermatitis—Bleomycin—skin cancer	6.08e-05	0.000355	CcSEcCtD
Isotretinoin—Hypersensitivity—Temozolomide—skin cancer	6e-05	0.00035	CcSEcCtD
Isotretinoin—Urticaria—Fluorouracil—skin cancer	5.96e-05	0.000348	CcSEcCtD
Isotretinoin—Syncope—Docetaxel—skin cancer	5.95e-05	0.000347	CcSEcCtD
Isotretinoin—Body temperature increased—Fluorouracil—skin cancer	5.93e-05	0.000346	CcSEcCtD
Isotretinoin—Palpitations—Docetaxel—skin cancer	5.87e-05	0.000342	CcSEcCtD
Isotretinoin—Asthenia—Temozolomide—skin cancer	5.84e-05	0.000341	CcSEcCtD
Isotretinoin—Loss of consciousness—Docetaxel—skin cancer	5.83e-05	0.00034	CcSEcCtD
Isotretinoin—Cough—Docetaxel—skin cancer	5.79e-05	0.000338	CcSEcCtD
Isotretinoin—Pruritus—Temozolomide—skin cancer	5.76e-05	0.000336	CcSEcCtD
Isotretinoin—Convulsion—Docetaxel—skin cancer	5.75e-05	0.000336	CcSEcCtD
Isotretinoin—Nausea—Bleomycin—skin cancer	5.74e-05	0.000335	CcSEcCtD
Isotretinoin—Hypertension—Docetaxel—skin cancer	5.73e-05	0.000334	CcSEcCtD
Isotretinoin—Vomiting—Dactinomycin—skin cancer	5.73e-05	0.000334	CcSEcCtD
Isotretinoin—Rash—Dactinomycin—skin cancer	5.68e-05	0.000331	CcSEcCtD
Isotretinoin—Arthralgia—Docetaxel—skin cancer	5.65e-05	0.00033	CcSEcCtD
Isotretinoin—Chest pain—Docetaxel—skin cancer	5.65e-05	0.00033	CcSEcCtD
Isotretinoin—Myalgia—Docetaxel—skin cancer	5.65e-05	0.00033	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	5.61e-05	0.000327	CcSEcCtD
Isotretinoin—Diarrhoea—Temozolomide—skin cancer	5.57e-05	0.000325	CcSEcCtD
Isotretinoin—Hypersensitivity—Fluorouracil—skin cancer	5.53e-05	0.000323	CcSEcCtD
Isotretinoin—Dry mouth—Docetaxel—skin cancer	5.53e-05	0.000322	CcSEcCtD
Isotretinoin—Confusional state—Docetaxel—skin cancer	5.46e-05	0.000319	CcSEcCtD
Isotretinoin—Anaphylactic shock—Docetaxel—skin cancer	5.42e-05	0.000316	CcSEcCtD
Isotretinoin—Oedema—Docetaxel—skin cancer	5.42e-05	0.000316	CcSEcCtD
Isotretinoin—Dizziness—Temozolomide—skin cancer	5.39e-05	0.000314	CcSEcCtD
Isotretinoin—Infection—Docetaxel—skin cancer	5.38e-05	0.000314	CcSEcCtD
Isotretinoin—Nausea—Dactinomycin—skin cancer	5.35e-05	0.000312	CcSEcCtD
Isotretinoin—Shock—Docetaxel—skin cancer	5.33e-05	0.000311	CcSEcCtD
Isotretinoin—Nervous system disorder—Docetaxel—skin cancer	5.31e-05	0.00031	CcSEcCtD
Isotretinoin—Pruritus—Fluorouracil—skin cancer	5.31e-05	0.00031	CcSEcCtD
Isotretinoin—Thrombocytopenia—Docetaxel—skin cancer	5.3e-05	0.000309	CcSEcCtD
Isotretinoin—Tachycardia—Docetaxel—skin cancer	5.29e-05	0.000309	CcSEcCtD
Isotretinoin—Skin disorder—Docetaxel—skin cancer	5.26e-05	0.000307	CcSEcCtD
Isotretinoin—Vomiting—Temozolomide—skin cancer	5.18e-05	0.000302	CcSEcCtD
Isotretinoin—Anorexia—Docetaxel—skin cancer	5.16e-05	0.000301	CcSEcCtD
Isotretinoin—Rash—Temozolomide—skin cancer	5.14e-05	0.0003	CcSEcCtD
Isotretinoin—Diarrhoea—Fluorouracil—skin cancer	5.14e-05	0.0003	CcSEcCtD
Isotretinoin—Dermatitis—Temozolomide—skin cancer	5.13e-05	0.000299	CcSEcCtD
Isotretinoin—Headache—Temozolomide—skin cancer	5.1e-05	0.000298	CcSEcCtD
Isotretinoin—Hypotension—Docetaxel—skin cancer	5.06e-05	0.000295	CcSEcCtD
Isotretinoin—Dizziness—Fluorouracil—skin cancer	4.96e-05	0.00029	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Docetaxel—skin cancer	4.94e-05	0.000288	CcSEcCtD
Isotretinoin—Insomnia—Docetaxel—skin cancer	4.9e-05	0.000286	CcSEcCtD
Isotretinoin—Paraesthesia—Docetaxel—skin cancer	4.86e-05	0.000284	CcSEcCtD
Isotretinoin—Nausea—Temozolomide—skin cancer	4.84e-05	0.000282	CcSEcCtD
Isotretinoin—Dyspnoea—Docetaxel—skin cancer	4.83e-05	0.000282	CcSEcCtD
Isotretinoin—Somnolence—Docetaxel—skin cancer	4.82e-05	0.000281	CcSEcCtD
Isotretinoin—Vomiting—Fluorouracil—skin cancer	4.77e-05	0.000278	CcSEcCtD
Isotretinoin—Dyspepsia—Docetaxel—skin cancer	4.77e-05	0.000278	CcSEcCtD
Isotretinoin—Rash—Fluorouracil—skin cancer	4.73e-05	0.000276	CcSEcCtD
Isotretinoin—Dermatitis—Fluorouracil—skin cancer	4.73e-05	0.000276	CcSEcCtD
Isotretinoin—Decreased appetite—Docetaxel—skin cancer	4.71e-05	0.000275	CcSEcCtD
Isotretinoin—Headache—Fluorouracil—skin cancer	4.7e-05	0.000274	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—skin cancer	4.68e-05	0.000273	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—skin cancer	4.67e-05	0.000273	CcSEcCtD
Isotretinoin—Pain—Docetaxel—skin cancer	4.63e-05	0.00027	CcSEcCtD
Isotretinoin—Constipation—Docetaxel—skin cancer	4.63e-05	0.00027	CcSEcCtD
Isotretinoin—Feeling abnormal—Docetaxel—skin cancer	4.46e-05	0.00026	CcSEcCtD
Isotretinoin—Nausea—Fluorouracil—skin cancer	4.46e-05	0.00026	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—skin cancer	4.43e-05	0.000258	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—skin cancer	4.28e-05	0.00025	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—skin cancer	4.28e-05	0.00025	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—skin cancer	3.99e-05	0.000233	CcSEcCtD
Isotretinoin—Asthenia—Docetaxel—skin cancer	3.89e-05	0.000227	CcSEcCtD
Isotretinoin—Pruritus—Docetaxel—skin cancer	3.83e-05	0.000224	CcSEcCtD
Isotretinoin—Diarrhoea—Docetaxel—skin cancer	3.71e-05	0.000216	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—skin cancer	3.58e-05	0.000209	CcSEcCtD
Isotretinoin—Vomiting—Docetaxel—skin cancer	3.44e-05	0.000201	CcSEcCtD
Isotretinoin—Rash—Docetaxel—skin cancer	3.42e-05	0.000199	CcSEcCtD
Isotretinoin—Dermatitis—Docetaxel—skin cancer	3.41e-05	0.000199	CcSEcCtD
Isotretinoin—Headache—Docetaxel—skin cancer	3.39e-05	0.000198	CcSEcCtD
Isotretinoin—Nausea—Docetaxel—skin cancer	3.22e-05	0.000188	CcSEcCtD
